Stockreport

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

VIRPAX PHARMS INC  (VRPX) 
PDF BERWYN, Penn.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products [Read more]